Your browser doesn't support javascript.
loading
CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicity.
Jess, Jennifer; Yates, Bonnie; Dulau-Florea, Alina; Parker, Kevin; Inglefield, Jon; Lichtenstein, Dan; Schischlik, Fiorella; Ongkeko, Martin; Wang, Yanyu; Shahani, Shilpa; Cullinane, Ann; Smith, Hannah; Kane, Eli; Little, Lauren; Chen, Dong; Fry, Terry J; Shalabi, Haneen; Wang, Hao-Wei; Satpathy, Ansuman; Lozier, Jay; Shah, Nirali N.
Afiliación
  • Jess J; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Yates B; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Dulau-Florea A; Department of Laboratory Medicine, National Institutes of Health, Bethesda, Maryland, USA.
  • Parker K; Department of Pathology, Stanford University, Stanford, California, USA.
  • Inglefield J; Applied Developmental Research Directorate, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
  • Lichtenstein D; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Schischlik F; Cancer Data Science Laboratory, National Cancer Institute, Bethesda, Maryland, USA.
  • Ongkeko M; Department of Transfusion Medicine, National Institutes of Health, Bethesda, Maryland, USA.
  • Wang Y; Applied Developmental Research Directorate, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
  • Shahani S; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Cullinane A; Department of Laboratory Medicine, National Institutes of Health, Bethesda, Maryland, USA.
  • Smith H; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Kane E; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Little L; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Chen D; Mayo Clinic, Rochester, Minnesota, USA.
  • Fry TJ; University of Colorado Denver Children's Hospital Colorado Research Institute, Aurora, Colorado, USA.
  • Shalabi H; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Wang HW; Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland, USA.
  • Satpathy A; Department of Pathology, Stanford University, Stanford, California, USA.
  • Lozier J; Department of Laboratory Medicine, National Institutes of Health, Bethesda, Maryland, USA.
  • Shah NN; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA nirali.shah@nih.gov.
J Immunother Cancer ; 11(6)2023 06.
Article en En | MEDLINE | ID: mdl-37295816
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trombocitopenia / Neoplasias Hematológicas Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Immunother Cancer Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trombocitopenia / Neoplasias Hematológicas Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Immunother Cancer Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido